General Info

Ambrx is a biopharmaceutical company that develops a range of protein-based drugs. Its ReCODE technology is used in multiple protein applications, including cytokines, peptides and antibodies. The company s technology is also helpful in various therapeutic areas. Its protein medicinal chemistry combines the power of medicinal chemistry with recombinant biosynthesis. The company also optimizes the pharmaceutical properties of lead candidate proteins. Located in La Jolla, Calif., Ambrx owns and controls a comprehensive intellectual property portfolio that dominates the incorporation of nonnative amino acids into biosynthetic proteins. The company is also an exclusive commercial licensee under the intellectual property rights owned by The Scripps Research Institute.